Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    Austria Czechia France Germany Spain
  • Study of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain
  • A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

    Recruiting

    2 1
    Investigated Diseases:
    Austria Belgium Germany Italy Poland Romania +2
  • Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

    Recruiting

    3 1 1 1
    Belgium Bulgaria Czechia France Germany Greece +5
  • Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium France Germany Hungary Italy The Netherlands +4
  • Adjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC

    Recruiting

    3 1 1 1
    Austria Belgium France Germany Greece Ireland +4
  • Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)

    Recruiting

    2 1 1
    Investigated Diseases:
    France Greece Hungary Portugal Spain Sweden
  • Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

    Recruiting

    3 1 1
    Finland France Germany Greece Hungary Italy +7
  • Cabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8